Gastric carcinoid: Germline and somatic mutation of the neurofibromatosis type 1 gene

Familial Cancer

Volumn 6, Issue 1, 2007, Pages 147-152

  Stewart, W ^a   Traynor, J P ^a   Cooke, A ^b   Griffiths, S ^c   Onen N F ^a   Balsitis, M ^a   Shah, A A ^a   Upadhyaya, M ^c   Tobias, E S ^b  

^a CROSSHOUSE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Gastric carcinoid; LOH; Neurofibromatosis; NF1

Indexed keywords

NEUROFIBROMIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TUMOR; GENE DELETION; GENE INACTIVATION; GENE LOCUS; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MICROSATELLITE INSTABILITY; NONSENSE MUTATION; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RISK FACTOR; SOMATIC MUTATION; STOMACH CANCER;

EID: 33847168544     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-006-9002-2     Document Type: Article

References (25)

1. Griffiths DF, Williams GT, Williams ED (1987) Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Q J Med 64:769-782
2. Hough DR, Chan A, Davidson H (1983) Von Recklinghausen's disease associated with gastrointestinal carcinoid tumors. Cancer 51:2206-2208
3. Karatzas G, Kouraklis G, Karayiannakis A et al (2000) Ampullary carcinoid and jejunal stromal tumour associated with von Recklinghausen's disease presenting as gastrointestinal bleeding and jaundice. Eur J Surg Oncol 26:428-429
4. Fuller CE, Williams GT (1991) Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology 19:1-11
5. Huson S (1994) Neurofibromatosis 1: a clinical and genetic overview. In: Huson S, Hughes R (eds) The neurofibromatoses: a pathogenetic and clinical overview. Chapman and Hall, London, pp 160-203
6. Burke AP, Sobin LH, Shekitka KM et al (1990) Somatostatin-producing duodenal carcinoids in patients with von Recklinghausen's neurofibromatosis. A predilection for black patients. Cancer 65:1591-1595
7. Upadhyaya M, Han S, Consoli C et al (2004) Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 23:134-146
8. Han SS, Cooper DN, Upadhyaya MN (2001) Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 109:487-497
9. Caplin ME, Buscombe JR, Hilson AJ et al (1998) Carcinoid tumour. Lancet 352:799-805
10. Lee HY, Garber PE (1970) Von Recklinghausen's disease associated with pheochromocytoma and carcinoid tumor. Ohio State Med J 66:583-586
11. Leotlela PD, Jauch A, Holtgreve-Grez H et al (2003) Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer 10:437-450
12. Wheeler MH, Curley IR, Williams ED (1986) The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery 100:1163-1169
13. Martin GA, Viskochil D, Bollag G et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843-849
14. von Deimling A, Krone W, Menon AG (1995) Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 5:153-162
15. Shen MH, Harper PS, Upadhyaya M (1996) Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 33:2-17
16. John AM, Ruggieri M, Ferner R et al (2000) A search for evidence of somatic mutations in the NF1 gene. J Med Genet 37:44-49
17. Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122-126
18. Xu W, Mulligan LM, Ponder MA et al (1992) Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 4:337-342
19. Upadhyaya M, Osborn M, Maynard J et al (1996) Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene. Am J Med Genet 67:421-423
20. Castle B, Baser ME, Huson SM et al (2003) Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet 40:e109
21. Ottini L, Esposito DL, Richetta A et al (1995) Alterations of microsatellites in neurofibromas of von Recklinghausen's disease. Cancer Res 55:5677-5680
22. Wang Q, Montmain G, Ruano E et al (2003) Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet 112:117-123
23. Ricciardone MD, Ozcelik T, Cevher B et al (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 59:290-293
24. Gallinger S, Aronson M, Shayan K et al (2004) Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 126:576-585
25. Kehrer-Sawatzki H, Tinschert S, Jenne DE (2003) Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region. J Med Genet 40:e116